These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 17924963
1. Steroid hormones and carcinogenesis of the prostate: the role of estrogens. Ricke WA, Wang Y, Cunha GR. Differentiation; 2007 Nov; 75(9):871-82. PubMed ID: 17924963 [Abstract] [Full Text] [Related]
2. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. Ho SM. J Cell Biochem; 2004 Feb 15; 91(3):491-503. PubMed ID: 14755680 [Abstract] [Full Text] [Related]
3. The dual, opposing roles of estrogen in the prostate. Ellem SJ, Risbridger GP. Ann N Y Acad Sci; 2009 Feb 15; 1155():174-86. PubMed ID: 19250203 [Abstract] [Full Text] [Related]
5. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. Ho SM, Leung YK, Chung I. Ann N Y Acad Sci; 2006 Nov 15; 1089():177-93. PubMed ID: 17261766 [Abstract] [Full Text] [Related]
9. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate. Adams JY, Leav I, Lau KM, Ho SM, Pflueger SM. Prostate; 2002 Jun 01; 52(1):69-81. PubMed ID: 11992621 [Abstract] [Full Text] [Related]
10. A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver. Singh PB, Matanhelia SS, Martin FL. Eur J Cancer; 2008 May 01; 44(7):928-36. PubMed ID: 18381236 [Abstract] [Full Text] [Related]
11. Role of stroma in carcinogenesis of the prostate. Cunha GR, Hayward SW, Wang YZ. Differentiation; 2002 Dec 01; 70(9-10):473-85. PubMed ID: 12492490 [Abstract] [Full Text] [Related]
12. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089. Perez-Stable CM, Schwartz GG, Farinas A, Finegold M, Binderup L, Howard GA, Roos BA. Cancer Epidemiol Biomarkers Prev; 2002 Jun 01; 11(6):555-63. PubMed ID: 12050097 [Abstract] [Full Text] [Related]
13. Estrogens and mechanisms of prostate cancer progression. Carruba G. Ann N Y Acad Sci; 2006 Nov 01; 1089():201-17. PubMed ID: 17261768 [Abstract] [Full Text] [Related]
14. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches. Hoffmann J, Sommer A. J Steroid Biochem Mol Biol; 2005 Feb 01; 93(2-5):191-200. PubMed ID: 15860262 [Abstract] [Full Text] [Related]
15. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H. Cancer Res; 2000 Sep 15; 60(18):5125-33. PubMed ID: 11016639 [Abstract] [Full Text] [Related]
16. Enzymes as modulators in malignant transformation. Vihko P, Herrala A, Härkönen P, Isomaa V, Kaija H, Kurkela R, Li Y, Patrikainen L, Pulkka A, Soronen P, Törn S. J Steroid Biochem Mol Biol; 2005 Feb 15; 93(2-5):277-83. PubMed ID: 15860271 [Abstract] [Full Text] [Related]
17. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Bonkhoff H, Berges R. Eur Urol; 2009 Mar 15; 55(3):533-42. PubMed ID: 19013008 [Abstract] [Full Text] [Related]
18. Sex steroid hormone metabolism and prostate cancer. Soronen P, Laiti M, Törn S, Härkönen P, Patrikainen L, Li Y, Pulkka A, Kurkela R, Herrala A, Kaija H, Isomaa V, Vihko P. J Steroid Biochem Mol Biol; 2004 Nov 15; 92(4):281-6. PubMed ID: 15663991 [Abstract] [Full Text] [Related]